FRESENIUS MEDICAL CARE AG Credit Suisse 2022 Global Healthcare Conference
MARCH 1, 2022
Dr. Dominik Heger
Head of Investor Relations, Strategic
Development & Communications | EVP
© Copyright
Safe harbor statement: This presentation includes certain forward-looking statements within the meaning of Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Act of 1934, as amended. Forward-looking statements are inherently subject to risks and uncertainties, many of which cannot be predicted with accuracy or might not even be anticipated. The Company has based these forward-looking statements on current estimates and assumptions which we believe are reasonable and which are made to the best of our knowledge. Actual results could differ materially from those included in the forward-looking statements due to various risk factors and uncertainties, including changes in business, economic or competitive conditions, changes in reimbursement, regulatory compliance issues, regulatory reforms, foreign exchange rate fluctuations, uncertainties in litigation or investigative proceedings, cyber security issues and the availability of financing. Given these uncertainties, readers should not put undue reliance on any forward-looking statements. These and other risks and uncertainties are discussed in detail in Fresenius Medical Care AG & Co. KGaA's (FMC AG & Co. KGaA) Annual Report on Form
20-F under the heading "Forward-Looking Statements" and under the headings in that report
referred to therein, and in FMC AG & Co. KGaA's other reports filed with the Securities and Exchange Commission (SEC) and the Frankfurt Stock Exchange (Frankfurter Wertpapierbörse).
Forward-looking statements represent estimates and assumptions only as of the date that they were made. The information contained in this presentation is subject to change without notice and the company does not undertake any duty to update the forward-looking statements, and the estimates and assumptions associated with them, except to the extent required by applicable law and regulations.
If not mentioned differently the term net income after minorities refers to the net income attributable to the shareholders of Fresenius Medical Care AG Co. KGaA. The term EMEA refers to the region Europe, Middle East and Africa. Amounts are in Euro if not mentioned otherwise.
Implementation of measures as presented herein may be subject to information & consultation procedures with works councils and other employee representative bodies, as per local laws and practice. Consultation procedures may lead to changes on proposed measures.
© Copyright
FY 2021 | Achieving Targets in a Challenging Year
- Financial targets for FY 2021 achieved
- Business development significantly impacted by COVID-19 in 2021, effects are expected to continue into 2022
- Decline in excess mortality in the fourth quarter
- 25th consecutive dividend increase to 1.35 EUR proposed
- Implementation of strategic priorities on track
© │ Credit Suisse 2022 Global Healthcare Conference | 3/1/2022 | Page 3 |
1 | |||
2 | |||
AGENDA | 3 | ||
4 | |||
5 | |||
Strategy Update
Medical Update
Business Update
Financials
Outlook
Key Drivers for our Core Dialysis Business remain intact
Addressing global health care challenges
AGEING GLOBAL
POPULATION
+150%
Global population aged 65+1
1.0 | ||
0.4 | ||
billion | ||
billion | ||
20002030
HYPERTENSION
One out of four people worldwide has hypertension!
People living
with hypertension2
DIABETES | DIALYSIS PATIENTS | |
+280% | +460% | |
People living | People on maintenance | |
with diabetes3 | dialysis4 |
578 | >6 | |||||
1.07 | ||||||
151 | ||||||
million | million | |||||
million | million | |||||
2000 | 2030 | 2000 | 2030 |
1 United Nations, Department of Economic and Social Affairs, Population Division (2019). World Population Prospects 2019, Volume II: Demographic Profiles (ST/ESA/SER.A/427) 2 WHO Global Health Observatory (people >18 years of age) | 3 IDF Diabetes Atlas 2019 (9th edition) | 4 FME Long Range Patient Projection 2020
© │ Credit Suisse 2022 Global Healthcare Conference | 3/1/2022 | Page 5 |
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
FMC - Fresenius Medical Care AG & Co. KGaA published this content on 01 March 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 04 March 2022 11:55:03 UTC.
